Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global Women’s Health Market to Grow at 5.7% CAGR through 2025

Press release Description

Albany, New York, March 12, 2018: A new comprehensive study titled “Women’s Health Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has recently been submitted to the repository of Market Research Reports Search Engine (MRRSE). The report provides 360 degree view of global market of women’s health by observing historical trends and forecasts the market from 2017 to 2025. According to the report, the global women’s health market is projected to grow at 5.7% CAGR through 2025.

The report studies the global women’s health market in detail, and offers a forecast on the basis of various factors that are likely to impact the market during the assessment period. Readers can expect a comprehensive and 360 degree view of market, with a detailed section of the product and business strategies of the key players. A lucid qualitative commentary on the key market dynamics has also been offered in the report.

In a bid to offer detailed insights on the global women’s health market, the report offers segment-wise analysis and forecast. The research study divides the global women’s health market into various segments to gain detailed insights and these segments are disease indication, treatment type and region. The disease indication segment is sub-segmented into cancer (ovarian, cervical and breast), menopause, contraceptive, urinary tract infection, hypothyroidism, osteoporosis and uterine fibroid. On the basis of treatment type, the global market is bifurcated into hormonal (estrogen, combination, thyroid, progestin, parathyroid and others) and non-hormonal (Targeted Drugs, Biphosphonates, Antibiotics and others. By geography, the report divides the global market into key regions which are North America, Latin America, Europe, Asia Pacific, Middle East and Africa.

According to the report, North America is the largest market for women’s health globally, on account of strong focus by government and private institutions. Although the healthcare system of Canada is also quite robust and comprehensive, the US accounts for the leading revenue share in North America on account of higher population and presence of leading players.

In addition to North America, Asia Pacific excluding Japan (APEJ) is also emerging as a lucrative market for women’s health globally. The adoption of women’s healthcare services in APEJ is growing on account of growing emphasis by government on revamping healthcare infrastructure.

The report also profiles the leading companies operating in the global women’s health market. Some of the companies profiled in the report are Eli Lilly and Company, Pfizer, Inc., Novo Nordisk A/S, AstraZeneca, Sanofi, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., F. Hoffmann-La Roche Ltd., Allergan Plc and Lupin Pharmaceuticals, Inc.

Browse Full Global Women’s Health Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559